Skip to main content

Neuronetics, Inc.

corporate_fare Company Profile

Neuronetics, Inc.

STIM·NASDAQ·Industrial Applications And Services·CIK 0001227636

Neuronetics, Inc. is a global neuroscience company focused on mental health, providing treatment options to patients and healthcare providers. The company's primary product is the NeuroStar Advanced Therapy System, a non-invasive, office-based treatment that uses transcranial magnetic stimulation (TMS). This system creates a pulsed, MRI-strength magnetic field to stimulate specific brain areas linked to mood. The NeuroStar Advanced Therapy System is cleared by the U.S. FDA to treat adult patients with major depressive disorder (MDD) who have not improved with prior antidepressant medication in their current MDD episode. It is also FDA-cleared as an adjunct for adults with obsessive-compulsive disorder (OCD) and for adolescent patients aged 15-21 with MDD. Additionally, it is FDA-cleared to reduce anxiety symptoms in adult MDD patients who also experience comorbid anxiety symptoms (anxious depression). Neuronetics sells the NeuroStar Advanced Therapy System and related treatment sessions. The company also operates Greenbrook treatment centers across the U.S., which are wholly owned subsidiaries offering NeuroStar Advanced Therapy. These centers also provide SPRAVATO® for adults with treatment-resistant depression or depressive symptoms in adults with MDD experiencing acute suicidal ideation or behavior. Neuronetics estimates that 237,574 global patients have been treated with over 8.5 million of their treatment sessions through December 31, 2025. For the year ended December 31, 2025, the company generated revenues of $149.2 million.

Neuronetics, Inc. (NASDAQ:STIM) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 38 items for STIM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for STIM spans SCHEDULE 13D/A, 424B5, 8-K, 10-Q.

Recent high-impact activity:

  • Activist Chernett Exits Neuronetics Stake, Selling 7.4M Shares in One Day
  • Neuronetics Prices $30M Offering at $1.60, a Discount to Monday's Close
  • Neuronetics Launches Underwritten Stock Offering to Fund Perceptive Paydown
  • Neuronetics Wins Covenant Relief Only by Prepaying $15M+ of Perceptive Debt by Nov 30
  • Neuronetics Launches Stock Offering to Fund $15M Lender Prepayment

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$149.16M
Net Income
-$39M
Diluted EPS
-$0.59
Op. Cash Flow
-$20.37M
Free Cash Flow
-$21.18M
Gross Profit
$72.31M
Operating Income
-$31.44M
Cash & Equivalents
$28.13M
Total Debt
$65.81M
Debt / Equity
2.94×
Net Margin
-26.1%
Shares Outstanding
68.99M sh
Source: 10-K · filed 2026-03-17 · accession 0001104659-26-029004

Short Interest & Short Volume

9.89 days to cover

FINRA reported short interest of 6,660,208 shares in STIM as of the October 30, 2026 settlement, a 7.6% decrease from the prior period — about 9.9 days to cover at its recent average daily volume. On November 20, 2026, 34.3% of STIM volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)6,660,208 shares as of October 30, 2026
Change vs prior period▼ 7.6%
Days to cover9.89 at avg daily volume of 673,520
Daily short volume (FINRA facilities)34.3% of 1,642,390 shares on November 20, 2026
5-day average short volume20.5%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for STIM, detected from its recent SEC filings · based on capital-structure filings through 2026-11-12.

1 recent capital raise

Final Prospectus for Priced Offering · Net Proceeds and Use

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with S →
$1.25
52-week range · as of 2026-11-16 $0.80 – $3.44
Market cap
$97.16M
Volume
3M (1.2× avg)
3-mo avg 2.5M
Live data · 2026-11-21 18:22 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed STIM - Latest Insights

STIM
Nov 16, 2026, 7:30 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $1.47
Real-time Price: $1.25 info
Change: -$0.2166 (-15%) info
Market Cap: $97.16M info
STIM
Nov 10, 2026, 10:40 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.76
Real-time Price: $1.25 info
Change: -$0.5103 (-29%) info
Market Cap: $97.16M info
STIM
Nov 10, 2026, 5:01 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $1.81
Real-time Price: $1.25 info
Change: -$0.560 (-31%) info
Market Cap: $97.16M info
STIM
Nov 10, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.80
Real-time Price: $1.25 info
Change: -$0.5501 (-31%) info
Market Cap: $97.16M info
STIM
Nov 10, 2026, 4:01 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.80
Real-time Price: $1.25 info
Change: -$0.5501 (-31%) info
Market Cap: $97.16M info
STIM
Nov 04, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $2.52
Real-time Price: $1.25 info
Change: -$1.27 (-50%) info
Market Cap: $97.16M info
STIM
Nov 04, 2026, 7:50 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $2.32
Real-time Price: $1.25 info
Change: -$1.07 (-46%) info
Market Cap: $97.16M info
STIM
Aug 11, 2026, 4:26 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $3.18
Real-time Price: $1.25 info
Change: -$1.93 (-61%) info
Market Cap: $97.16M info
STIM
Aug 11, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.50
Real-time Price: $1.25 info
Change: -$1.25 (-50%) info
Market Cap: $97.16M info
STIM
Aug 11, 2026, 7:50 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.39
Real-time Price: $1.25 info
Change: -$1.14 (-48%) info
Market Cap: $97.16M info
STIM
Aug 04, 2026, 8:00 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $2.16
Real-time Price: $1.25 info
Change: -$0.910 (-42%) info
Market Cap: $97.16M info
STIM
Jul 20, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.00
Real-time Price: $1.25 info
Change: -$0.750 (-38%) info
Market Cap: $97.16M info
STIM
May 29, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.54
Real-time Price: $1.25 info
Change: -$0.2887 (-19%) info
Market Cap: $97.16M info
STIM
May 27, 2026, 10:33 AM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.26
Real-time Price: $1.25 info
Change: -$0.0050 (-0.40%) info
Market Cap: $97.16M info
STIM
May 14, 2026, 8:32 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.48
Real-time Price: $1.25 info
Change: -$0.230 (-16%) info
Market Cap: $97.16M info
STIM
May 13, 2026, 8:31 AM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $1.36
Real-time Price: $1.25 info
Change: -$0.110 (-8%) info
Market Cap: $97.16M info
STIM
May 05, 2026, 9:10 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $2.08
Real-time Price: $1.25 info
Change: -$0.830 (-40%) info
Market Cap: $97.16M info
STIM
May 05, 2026, 8:04 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.09
Real-time Price: $1.25 info
Change: -$0.8388 (-40%) info
Market Cap: $97.16M info
STIM
May 05, 2026, 7:58 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $2.09
Real-time Price: $1.25 info
Change: -$0.840 (-40%) info
Market Cap: $97.16M info
STIM
Apr 13, 2026, 8:32 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.35
Real-time Price: $1.25 info
Change: -$0.100 (-7%) info
Market Cap: $97.16M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets